BOLD MRI Can Detect Coronary Stenosis at Rest
By MedImaging International staff writers Posted on 26 Jul 2016 |
Image: A patient about to undergo an MRI scan (Photo courtesy of MNT).
A new study suggests that blood oxygen-level dependent (BOLD) magnetic resonance imaging (MRI) can detect myocardial ischemia without inducing cardiac physiological or pharmacological stress.
Researchers at John Radcliffe Hospital (Oxford, United Kingdom) conducted a study to reevaluate data published in 2012 that focused more on segment-based analysis of BOLD, whereas the new analysis focused on whole-slice analysis. In the first study, which included 25 coronary artery disease (CAD) patients and 20 healthy volunteers, the researchers determined the diagnostic performance of stress BOLD imaging in identifying significant CAD.
For the present analysis, resting BOLD signal intensity was first evaluated in the derivation group, and then tested in a separate validation group of 57 patients with suspected CAD referred for diagnostic coronary angiography. The range of BOLD signals at rest for each patient was indexed to create a score that correlated with presence of CAD, with an average index of 22.6% in those with versus 15.4% for those without ischemia. The researchers therefore defined a 16.1% cutoff score that identified ischemia-causing blockages.
Upon validation, the researchers found that the BOLD model could identify blockages with 88% sensitivity, 58% specificity, and 75% overall diagnostic accuracy. It performed similarly for diagnosing anatomically-significant CAD--defined as 50% or greater stenosis--at 82% sensitivity, 61% specificity, and 75% overall diagnostic accuracy. The researchers also concluded that BOLD MRI could perform equally well at stress as at rest. The study was published in the July 2016 issue of JACC: Cardiovascular Imaging.
“Our findings are pertinent to alternative imaging modalities with the potential to identify microvascular heterogeneity, and advance the concept of a functional assessment of CAD being performed at rest,” concluded lead author Jayant Ranjit Arnold, BMBCh, MA, and colleagues. “The inability of resting myocardial blood flow to discriminate the presence of CAD indicates that the favorable diagnostic performance of resting BOLD assessment is not dependent on changes in resting myocardial blood flow.”
BOLD MRI measures the blood oxygen level dependent signal that is associated with changes in blood flow and oxygenation following neural activity. The technique is particularly helpful in neurology for patients with premotor symptoms of Parkinson’s disease (PD) such as frontal executive dysfunction. The neuroimaging provides excellent resolution and diagnostic sensitivity, and can facilitate the diagnosis of other neurodegenerative conditions, including multiple system atrophy, corticobasal degeneration, and progressive supranuclear palsy.
Related Links:
John Radcliffe Hospital
Researchers at John Radcliffe Hospital (Oxford, United Kingdom) conducted a study to reevaluate data published in 2012 that focused more on segment-based analysis of BOLD, whereas the new analysis focused on whole-slice analysis. In the first study, which included 25 coronary artery disease (CAD) patients and 20 healthy volunteers, the researchers determined the diagnostic performance of stress BOLD imaging in identifying significant CAD.
For the present analysis, resting BOLD signal intensity was first evaluated in the derivation group, and then tested in a separate validation group of 57 patients with suspected CAD referred for diagnostic coronary angiography. The range of BOLD signals at rest for each patient was indexed to create a score that correlated with presence of CAD, with an average index of 22.6% in those with versus 15.4% for those without ischemia. The researchers therefore defined a 16.1% cutoff score that identified ischemia-causing blockages.
Upon validation, the researchers found that the BOLD model could identify blockages with 88% sensitivity, 58% specificity, and 75% overall diagnostic accuracy. It performed similarly for diagnosing anatomically-significant CAD--defined as 50% or greater stenosis--at 82% sensitivity, 61% specificity, and 75% overall diagnostic accuracy. The researchers also concluded that BOLD MRI could perform equally well at stress as at rest. The study was published in the July 2016 issue of JACC: Cardiovascular Imaging.
“Our findings are pertinent to alternative imaging modalities with the potential to identify microvascular heterogeneity, and advance the concept of a functional assessment of CAD being performed at rest,” concluded lead author Jayant Ranjit Arnold, BMBCh, MA, and colleagues. “The inability of resting myocardial blood flow to discriminate the presence of CAD indicates that the favorable diagnostic performance of resting BOLD assessment is not dependent on changes in resting myocardial blood flow.”
BOLD MRI measures the blood oxygen level dependent signal that is associated with changes in blood flow and oxygenation following neural activity. The technique is particularly helpful in neurology for patients with premotor symptoms of Parkinson’s disease (PD) such as frontal executive dysfunction. The neuroimaging provides excellent resolution and diagnostic sensitivity, and can facilitate the diagnosis of other neurodegenerative conditions, including multiple system atrophy, corticobasal degeneration, and progressive supranuclear palsy.
Related Links:
John Radcliffe Hospital
Latest MRI News
- Low-Cost Whole-Body MRI Device Combined with AI Generates High-Quality Results
- World's First Whole-Body Ultra-High Field MRI Officially Comes To Market
- World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer